Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R L Murphy

Showing results (81-90 of 110) with videos related to

Pageof 11
Sort By:
AIDS (London, England)|April 1, 1994
Phase II dose-ranging trial of foscarnet salvage therapy for cytomegalovirus retinitis in AIDS patients intolerant of or resistant to ganciclovir (ACTG protocol 093). AIDS Clinical Trials Group of the National Institute of Allergy and Infectious DiseasesM A Jacobson, M Wulfsohn, J E Feinberg, et al.
Journal of Acquired Immune Deficiency Syndromes|October 11, 1992
Pneumocystis carinii choroiditis in patients with AIDS: clinical features, response to therapy, and outcomeB E Sha, C A Benson, T Deutsch, et al.
African Journal of Medicine and Medical Sciences|July 8, 2017
Is there any relationship between hearing threshold levels and CD4 cell count of human immunodeficiency virus infected adults?A J Fasunla, J O Ijitola, O M Akpa, et al.
The Journal of Infectious Diseases|April 27, 2000
The effects of protease inhibitor therapy on human immunodeficiency virus type 1 levels in semen (AIDS clinical trials group protocol 850)J J Eron, L M Smeaton, S A Fiscus, et al.
AIDS Research and Human Retroviruses|October 23, 2010
Impact of HIV type 1 subtype on drug resistance mutations in Nigerian patients failing first-line therapyB Chaplin, G Eisen, J Idoko, et al.
The American Journal of Medicine|April 1, 1991
Aerosol pentamidine prophylaxis following Pneumocystis carinii pneumonia in AIDS patients: results of a blinded dose-comparison study using an ultrasonic nebulizerR L Murphy, J P Lavelle, J D Allan, et al.
AIDS (London, England)|August 16, 2001
A prospective study of discontinuing primary and secondary Pneumocystis carinii pneumonia prophylaxis after CD4 cell count increase to > 200 x 106 /lS L Koletar, A E Heald, D Finkelstein, et al.
The Journal of Infectious Diseases|November 1, 1991
Prevalence of measles antibodies in asymptomatic human immunodeficiency virus-infected adultsB E Sha, A A Harris, C A Benson, et al.
AIDS (London, England)|December 12, 2001
Nevirapine-containing antiretroviral therapy in HIV-1 infected patients results in an anti-atherogenic lipid profileM van der Valk, J J Kastelein, R L Murphy, et al.
AIDS (London, England)|September 13, 2000
A comparison of stavudine, didanosine and indinavir with zidovudine, lamivudine and indinavir for the initial treatment of HIV-1 infected individuals: selection of thymidine analog regimen therapy (START II)J J Eron, R L Murphy, D Peterson, et al.
Pageof 11

Showing results (81-90 of 110) with videos related to

Sort By:
Pageof 11
AIDS (London, England)|April 1, 1994
Phase II dose-ranging trial of foscarnet salvage therapy for cytomegalovirus retinitis in AIDS patients intolerant of or resistant to ganciclovir (ACTG protocol 093). AIDS Clinical Trials Group of the National Institute of Allergy and Infectious DiseasesM A Jacobson, M Wulfsohn, J E Feinberg, et al.
Journal of Acquired Immune Deficiency Syndromes|October 11, 1992
Pneumocystis carinii choroiditis in patients with AIDS: clinical features, response to therapy, and outcomeB E Sha, C A Benson, T Deutsch, et al.
African Journal of Medicine and Medical Sciences|July 8, 2017
Is there any relationship between hearing threshold levels and CD4 cell count of human immunodeficiency virus infected adults?A J Fasunla, J O Ijitola, O M Akpa, et al.
The Journal of Infectious Diseases|April 27, 2000
The effects of protease inhibitor therapy on human immunodeficiency virus type 1 levels in semen (AIDS clinical trials group protocol 850)J J Eron, L M Smeaton, S A Fiscus, et al.
AIDS Research and Human Retroviruses|October 23, 2010
Impact of HIV type 1 subtype on drug resistance mutations in Nigerian patients failing first-line therapyB Chaplin, G Eisen, J Idoko, et al.
The American Journal of Medicine|April 1, 1991
Aerosol pentamidine prophylaxis following Pneumocystis carinii pneumonia in AIDS patients: results of a blinded dose-comparison study using an ultrasonic nebulizerR L Murphy, J P Lavelle, J D Allan, et al.
AIDS (London, England)|August 16, 2001
A prospective study of discontinuing primary and secondary Pneumocystis carinii pneumonia prophylaxis after CD4 cell count increase to > 200 x 106 /lS L Koletar, A E Heald, D Finkelstein, et al.
The Journal of Infectious Diseases|November 1, 1991
Prevalence of measles antibodies in asymptomatic human immunodeficiency virus-infected adultsB E Sha, A A Harris, C A Benson, et al.
AIDS (London, England)|December 12, 2001
Nevirapine-containing antiretroviral therapy in HIV-1 infected patients results in an anti-atherogenic lipid profileM van der Valk, J J Kastelein, R L Murphy, et al.
AIDS (London, England)|September 13, 2000
A comparison of stavudine, didanosine and indinavir with zidovudine, lamivudine and indinavir for the initial treatment of HIV-1 infected individuals: selection of thymidine analog regimen therapy (START II)J J Eron, R L Murphy, D Peterson, et al.
Pageof 11